Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.910
-0.095 (-3.16%)
Nov 2, 2026, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 950.25 million as of November 2, 2026. It is the 24,576th most valuable company in the world and the 168th biggest in Norway. Its market cap has increased by 22.17% in one year.
Market Cap
950.25M
Enterprise Value
524.24M
Revenue
4.60M
Global Rank
Country Rank
#168 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 950.25M, a decrease of -82.80%. That is a compound annual growth rate of -22.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 950.25M | 20.65% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.97B |
| Thor Medical ASA | 1.70B |
| ArcticZymes Technologies ASA | 1.10B |
| Lytix Biopharma ASA | 607.51M |
| Zelluna ASA | 513.60M |
| Oncoinvent ASA | 422.86M |
| SoftOx Solutions AS | 292.63M |
| Aqua Bio Technology ASA | 66.30M |